BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9495620)

  • 21. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early target organ damage and its reversibility: the heart.
    Rosei EA; Muiesan ML
    Clin Exp Hypertens; 2004; 26(7-8):673-87. PubMed ID: 15702622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Left ventricular hypertrophy: pathogenesis, diagnosis and therapy].
    Nagy V
    Orv Hetil; 2001 Jul; 142(26):1375-83. PubMed ID: 11478033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardio-protection and cardio-reparation in systemic arterial hypertension].
    Vallés Belsué F; Anguita Sánchez M
    Rev Esp Cardiol; 1997; 50 Suppl 4():49-52. PubMed ID: 9411587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
    Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of left ventricular hypertrophy: do antihypertensive classes differ?
    Sheridan DJ
    J Hypertens Suppl; 2000 Jul; 18(3):S21-7. PubMed ID: 10952084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention, diagnosis, and treatment of hypertensive heart disease.
    Georgiopoulou VV; Kalogeropoulos AP; Raggi P; Butler J
    Cardiol Clin; 2010 Nov; 28(4):675-91. PubMed ID: 20937450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
    Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
    Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antihypertensive therapy on left ventricular hypertrophy and on its pathophysiologic sequelae.
    Messerli FH
    Blood Press Suppl; 1992; 1():35-6; discussion 37. PubMed ID: 1343271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical methods for the detection and management of left ventricular hypertrophy.
    Swamy RS; Lang RM
    Indian Heart J; 2010; 62(5):384-7. PubMed ID: 23189877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.
    Kaplinsky E
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():549-56. PubMed ID: 7841088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Left ventricular hypertrophy: a real compensatory mechanism?].
    Guéret P; Bensaid J
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():77-82. PubMed ID: 8215784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of antihypertensive agents on the left ventricle: clinical implications.
    Díez J; González A; López B; Ravassa S; Fortuño MA
    Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.